Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
With
BrainCells Inc.
Up to approximately 120 adult outpatients meeting the study's inclusion and exclusion criteria may be enrolled in the study.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who are willing to provide written informed consent and who have completed participation in Protocol CBM-IT-01 are eligible for the study.
Eligible subjects will have demonstrated compliance with all CBM-IT-01's protocol requirements.
Clareo Health | Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)
